-
Loading metrics
Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial
- David A. Cooper,
- Damien V. Cordery,
- Roberto Zajdenverg,
- Kiat Ruxrungtham,
- Keikawus Arastéh,
- Frank Bergmann,
- José L. de Andrade Neto,
- Joseph Scherer,
- Ricardo L. Chaves,
- Patrick Robinson
x
- Published: January 5, 2016
- https://doi.org/10.1371/journal.pone.0144917